Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia-Reference-Cited by-同舟云学术

Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia

Published:2014-05-14 Issue:18 Volume:311 Page:1870
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Robinson Jennifer G.¹,Nedergaard Bettina S.²,Rogers William J.³,Fialkow Jonathan⁴,Neutel Joel M.⁵,Ramstad David⁶,Somaratne Ransi⁷,Legg Jason C.⁷,Nelson Patric⁷,Scott Rob⁷,Wasserman Scott M.⁷,Weiss Robert⁸

Affiliation:

1. Department of Epidemiology, College of Public Health, University of Iowa, Iowa City2Department of Medicine, College of Public Health, University of Iowa, Iowa City

2. Center for Clinical and Basic Research, Aalborg, Denmark

3. Division of Cardiovascular Disease, University of Alabama Medical Center, Birmingham

4. Department of Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami

5. Orange County Research Center, Tustin, California

6. Hampton Roads Center for Clinical Research, Suffolk, Virginia

7. Amgen Inc, Thousand Oaks, California

8. Maine Research Associates, Auburn

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 436 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Alirocumab, Evolocumab, and Inclisiran in Patients with Hypercholesterolemia at Increased Cardiovascular Risk;Medicina;2024-07-12

2. Impact of PCSK9 Inhibitors on Lipoprotein(a): A Meta-analysis and Meta-regression of Randomized Controlled Trials;2024-07-11

3. PCSK9 inhibitors and inclisiran with or without statin therapy on incident muscle symptoms and creatine kinase: a systematic review and network meta-analysis;Frontiers in Cardiovascular Medicine;2024-07-08

4. Uso de nuevas terapias hipolipemiantes en la práctica clínica. Consenso SEC/SEA/SEEN/SEMFYC/SEMERGEN/SEMG/SEN/SEACV/S.E.N.;REC: CardioClinics;2024-07

5. New Insights Into the Treatment of Hyperlipidemia: Pharmacological Updates and Emerging Treatments;Cureus;2024-06-24